-
Ocaliva Black-Box Warning About Liver Failure Due To Incorrect Doses Added In Early 2018
This Ocaliva Label Change Follows September 2017 Dear Doctor Letter Sent By Intercept Pharmaceuticals (Posted by Tom Lamb at DrugInjuryWatch.com) An earlier blog post, "Will Ocaliva Get Black-Box Warning For Liver Injury…
-
Diet Drug Saxenda May Increase Pancreatic Cancer Risks For Patients Only Wanting Weight Loss
Saxenda Dose Contains Twice As Much Liraglutide As Diabetes Medicine Victoza, Also Linked To Malignancy In Pancreas (Posted by Tom Lamb at DrugInjuryWatch.com) In 2014, the FDA approved Saxenda (liraglutide) for the…
-
2018 Emerging Drug Litigations: Viberzi and Actemra
Additional information concerning the potentially harmful side effects of Viberzi and Actemra was released over the course of 2017, and we will continue to monitor the situation in 2018.
-
2018 Emerging Drug Litigations: Mirena IUD and Ocaliva
Additional information concerning the potentially harmful side effects of the Mirena IUD and Ocaliva was released over the course of 2017, and we will continue to monitor the situation in 2018.
-
Drug-Induced Liver Injury Warning Added To OFEV Label In Canada As Done Earlier In US
This Relatively New Idiopathic Pulmonary Fibrosis (IPF) Pill Is Clearly On The Radar Of Drug Safety Regulators (Posted by Tom Lamb at DrugInjuryWatch.com) OFEV (nintedanib) capsules were approved by the FDA in 2014…
-
Drug Injury Watch: 2017 Collection Of Articles / Blog Posts
Written by: Heather Helmendach, Legal Assistant Law Offices of Thomas J. Lamb, P.A. At the Law Offices of Thomas J. Lamb, we are committed to providing up-to-date information on matters pertaining to drug…
